Internal Medicine, Rheumatology · Mobile, AL
NPI
1063679520
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
101 Memorial Hospital Dr, Suite 200
Mobile, AL, 36608
Phone (251) 414-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
101,445 services
Medicare patients, 2024
384
Average age 71
Drug cost, 2024
$3.7M
3,832 prescriptions
Company payments, 2025
$106
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deepak Kumar was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 61,200 times for 19 patients. In total Deepak Kumar billed 101,445 services in 105 codes, and Medicare paid $1.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-18.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 61,200 | 19 | $3.58 | $219K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 15,925 | 24 | $33.61 | $535K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 7,250 | 25 | $24.75 | $179K |
| 99214 Office E&M - Established | Office | 741 | 321 | $79.64 | $59K |
| 36415 Venipuncture Blood Collection | Office | 642 | 267 | $5.88 | $3,775 |
| 85025 Blood Count | Office | 510 | 233 | $7.50 | $3,825 |
| 80053 Clinical Chemistry | Office | 451 | 214 | $10.17 | $4,589 |
| 96372 Injection Administration | Office | 326 | 34 | $10.11 | $3,297 |
| 73130 X-ray - Upper Extremity | Office | 274 | 137 | $19.08 | $5,229 |
| 96365 Intravenous Infusion, Hydration | Office | 246 | 28 | $42.91 | $11K |
| 73630 X-ray - Lower Extremity | Office | 211 | 105 | $17.44 | $3,681 |
| 86140 Clinical Chemistry | Office | 194 | 146 | $5.00 | $971 |
| 85652 Clinical Chemistry | Office | 176 | 135 | $2.60 | $458 |
| 96413 Chemotherapy Administration | Office | 153 | 32 | $83.82 | $13K |
| 86160 Immunoassay | Office | 145 | 56 | $11.53 | $1,673 |
By year: 2022 $1.2M for 85,630 services; 2023 $1.1M for 99,844 services; 2024 $1.2M for 101,445 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 642 | 267 | $5.88 | $3,775 |
| 85025 Blood Count | 510 | 233 | $7.50 | $3,825 |
| 80053 Clinical Chemistry | 451 | 214 | $10.17 | $4,589 |
| 86140 Clinical Chemistry | 194 | 146 | $5.00 | $971 |
| 85652 Clinical Chemistry | 176 | 135 | $2.60 | $458 |
| 86160 Immunoassay | 145 | 56 | $11.53 | $1,673 |
| 84550 Clinical Chemistry | 80 | 47 | $4.36 | $349 |
| 86431 Immunoassay | 58 | 58 | $5.55 | $322 |
| 80048 Clinical Chemistry | 45 | 36 | $8.14 | $366 |
| 82550 Clinical Chemistry | 35 | 32 | $6.38 | $223 |
Medicare prescription drug claims, 2024
In 2024, the drug Deepak Kumar prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,089 prescriptions and refills. In total Deepak Kumar wrote 3,832 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,089 | 2,906 | 368 | $76K |
| Prednisone Generic | 479 | 624 | 256 | $2,301 |
| Methotrexate Methotrexate Sodium | 347 | 801 | 113 | $8,214 |
| Allopurinol Generic | 225 | 617 | 71 | $3,095 |
| Gabapentin Generic | 145 | 343 | 34 | $2,336 |
| Enbrel Sureclick Etanercept | 114 | 122 | 17 | $975K |
| Leflunomide Generic | 112 | 242 | 33 | $6,660 |
| Tramadol Hcl Generic | 102 | 119 | 18 | $918 |
| Febuxostat Generic | 97 | 223 | 29 | $11K |
| Sulfasalazine Generic | 93 | 226 | 33 | $2,586 |
| Meloxicam Generic | 84 | 186 | 30 | $455 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 83 | 85 | Under 11 | $1,790 |
| Orencia Abatacept/Maltose | 82 | 90 | 12 | $410K |
| Folic Acid Generic | 57 | 169 | 22 | $369 |
| Humira(Cf) Pen Adalimumab | 45 | 50 | Under 11 | $362K |
Brand drugs: 606 claims; generic drugs: 3,226 claims; opioid claims: 199.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deepak Kumar $106 ($106 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbvie Inc. with $45.69.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.